JAMES SCHULTZ: Open Payments
NPI 1770814766 · JOHNSON CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,511 in 97 payments from 14 companies in 2025. Trend: 2023 $1,192 · 2024 $1,066 · 2025 $1,511
Food & beverage: $1,511
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 29 | $601 |
| ABBVIE INC. | 31 | $272 |
| Novo Nordisk Inc | 13 | $192 |
| Lilly USA, LLC | 4 | $77 |
| PFIZER INC. | 4 | $75 |
| Exact Sciences Corporation | 4 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Astellas Pharma US Inc | 1 | $29 |
Products named: AIRSUPRA, BREZTRI, Ozempic, VRAYLAR, UBRELVY, QULIPTA, NURTEC ODT, FARXIGA.
Industry payments across TN — which companies pay providers there.
